Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas P Restifo

Showing results (21-30 of 260) with videos related to

Pageof 26
Sort By:
Cell Research|August 24, 2022
Fine-tuning T cell function through engineered orthogonal chimeric cytokine receptorsRigel J Kishton, Nicholas P Restifo
Nature Biotechnology|January 11, 2013
Double or nothing on cancer immunotherapyKen-ichi Hanada, Nicholas P Restifo
Nature Biotechnology|October 22, 2013
Reassessing target antigens for adoptive T-cell therapyChristian S Hinrichs, Nicholas P Restifo
Science (New York, N.Y.)|April 4, 2015
Adoptive cell transfer as personalized immunotherapy for human cancerSteven A Rosenberg, Nicholas P Restifo
Nature Cancer|December 17, 2024
T cells lead the charge against solid tumorsRigel J Kishton, Nicholas P Restifo
Nature Immunology|October 31, 2002
Natural selection of tumor variants in the generation of "tumor escape" phenotypesHung T Khong, Nicholas P Restifo
The Journal of Clinical Investigation|July 4, 2003
DNA vaccines and apoptosis: to kill or not to kill?Wolfgang W Leitner, Nicholas P Restifo
Blood|May 5, 2012
The power and pitfalls of IL-12Sid P Kerkar, Nicholas P Restifo
Trends in Immunology|November 3, 2009
Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and functionDouglas C Palmer, Nicholas P Restifo
Cell|September 12, 2015
Nutrient Competition: A New Axis of Tumor ImmunosuppressionMadhusudhanan Sukumar, Rahul Roychoudhuri, Nicholas P Restifo
Pageof 26

Showing results (21-30 of 260) with videos related to

Sort By:
Pageof 26
Cell Research|August 24, 2022
Fine-tuning T cell function through engineered orthogonal chimeric cytokine receptorsRigel J Kishton, Nicholas P Restifo
Nature Biotechnology|January 11, 2013
Double or nothing on cancer immunotherapyKen-ichi Hanada, Nicholas P Restifo
Nature Biotechnology|October 22, 2013
Reassessing target antigens for adoptive T-cell therapyChristian S Hinrichs, Nicholas P Restifo
Science (New York, N.Y.)|April 4, 2015
Adoptive cell transfer as personalized immunotherapy for human cancerSteven A Rosenberg, Nicholas P Restifo
Nature Cancer|December 17, 2024
T cells lead the charge against solid tumorsRigel J Kishton, Nicholas P Restifo
Nature Immunology|October 31, 2002
Natural selection of tumor variants in the generation of "tumor escape" phenotypesHung T Khong, Nicholas P Restifo
The Journal of Clinical Investigation|July 4, 2003
DNA vaccines and apoptosis: to kill or not to kill?Wolfgang W Leitner, Nicholas P Restifo
Blood|May 5, 2012
The power and pitfalls of IL-12Sid P Kerkar, Nicholas P Restifo
Trends in Immunology|November 3, 2009
Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and functionDouglas C Palmer, Nicholas P Restifo
Cell|September 12, 2015
Nutrient Competition: A New Axis of Tumor ImmunosuppressionMadhusudhanan Sukumar, Rahul Roychoudhuri, Nicholas P Restifo
Pageof 26